These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. A comparison of the abilities of typical neuroleptic agents and of thioridazine, clozapine, sulpiride and metoclopramide to antagonise the hyperactivity induced by dopamine applied intracerebrally to areas of the extrapyramidal and mesolimbic systems. Costall B, Naylor RJ. Eur J Pharmacol; 1976 Nov; 40(1):9-19. PubMed ID: 791660 [Abstract] [Full Text] [Related]
5. Stereoisomers of the atypical neuroleptic carbidine modulate striatal dopamine release in awake rats. Guinetdinov RR, Bogdanov MB, Pogorelov VM, Kudrin VS, Rayevsky KS. Neuropharmacology; 1991 Nov; 30(11):1251-4. PubMed ID: 1685561 [Abstract] [Full Text] [Related]
6. Remoxipride shows low propensity to block functional striatal dopamine D2 receptors in vitro. Westlind-Danielsson A, Gustafsson K, Andersson I. Eur J Pharmacol; 1994 Dec 15; 288(1):89-95. PubMed ID: 7705472 [Abstract] [Full Text] [Related]
7. The atypical antipsychotic, remoxipride, blocks phencyclidine-induced disruption of prepulse inhibition in the rat. Johansson C, Jackson DM, Svensson L. Psychopharmacology (Berl); 1994 Dec 15; 116(4):437-42. PubMed ID: 7701046 [Abstract] [Full Text] [Related]
11. Actions of dopamine antagonists on stimulated striatal and limbic dopamine release: an in vivo voltammetric study. Stamford JA, Kruk ZL, Millar J. Br J Pharmacol; 1988 Jul 15; 94(3):924-32. PubMed ID: 2902896 [Abstract] [Full Text] [Related]
12. Chronic treatment with classical and atypical antipsychotic drugs differentially decreases dopamine release in striatum and nucleus accumbens in vivo. Blaha CD, Lane RF. Neurosci Lett; 1987 Jul 22; 78(2):199-204. PubMed ID: 2888060 [Abstract] [Full Text] [Related]
13. Antagonism of the hyperactivity induced by dopamine applied intracerebrally to the nucleus accumbens septi by typical neuroleptics and by clozapine, sulpiride and thioridazine. Costall B, Naylor RJ. Eur J Pharmacol; 1976 Jan 22; 35(1):161-8. PubMed ID: 1253817 [Abstract] [Full Text] [Related]
14. The contrasting effects of neuroleptics on transmitter release from the nucleus accumbens and corpus striatum. de Belleroche JS, Neal MJ. Neuropharmacology; 1982 Jun 22; 21(6):529-37. PubMed ID: 6125910 [Abstract] [Full Text] [Related]
15. Dopamine receptor subtypes: differential regulation after 8 months treatment with antipsychotic drugs. Florijn WJ, Tarazi FI, Creese I. J Pharmacol Exp Ther; 1997 Feb 22; 280(2):561-9. PubMed ID: 9023264 [Abstract] [Full Text] [Related]
16. Comparison of effects of tiapride and sulpiride on D-1, D-2, D-3 and D-4 subtypes of dopamine receptors in rat striatal and bovine caudate nucleus membranes. Arima T, Samura N, Nomura Y, Segawa T. Jpn J Pharmacol; 1986 Jul 22; 41(3):419-23. PubMed ID: 3761757 [Abstract] [Full Text] [Related]
17. [Effect of the atypical neuroleptics carbidine and sulpiride on dopamine biosynthesis in the synaptosomes of the nucleus accumbens septi in rats]. Kudrin VS, Hetey L, Morgenshtern R, Raevskiĭ KS, Olssner W. Farmakol Toksikol; 1987 Jul 22; 50(2):16-20. PubMed ID: 2884129 [Abstract] [Full Text] [Related]
19. Effects of acute and chronic clozapine and haloperidol on in vitro release of acetylcholine and dopamine from striatum and nucleus accumbens. Compton DR, Johnson KM. J Pharmacol Exp Ther; 1989 Feb 22; 248(2):521-30. PubMed ID: 2918468 [Abstract] [Full Text] [Related]